NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 36 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $518,681 | +48059.8% | 2,727,027 | 0.0% | 0.04% | -52.6% |
| Q3 2022 | $1,077 | -62.4% | 2,727,027 | 0.0% | 0.08% | -65.9% |
| Q2 2022 | $2,863 | -44.2% | 2,727,027 | 0.0% | 0.22% | -31.6% |
| Q1 2022 | $5,127 | -33.1% | 2,727,027 | 0.0% | 0.33% | -25.6% |
| Q4 2021 | $7,663 | -22.2% | 2,727,027 | 0.0% | 0.44% | -33.6% |
| Q3 2021 | $9,844 | -24.6% | 2,727,027 | 0.0% | 0.66% | -19.5% |
| Q2 2021 | $13,062 | -12.8% | 2,727,027 | +34.5% | 0.82% | -21.4% |
| Q1 2021 | $14,980 | +5.7% | 2,027,027 | 0.0% | 1.04% | +22.4% |
| Q4 2020 | $14,169 | -7.9% | 2,027,027 | 0.0% | 0.85% | -32.2% |
| Q3 2020 | $15,386 | -7.9% | 2,027,027 | +6.5% | 1.26% | -30.7% |
| Q2 2020 | $16,711 | +52.6% | 1,903,227 | +23.7% | 1.81% | +16.1% |
| Q1 2020 | $10,954 | -1.1% | 1,538,462 | 0.0% | 1.56% | +89.9% |
| Q4 2019 | $11,077 | +44.3% | 1,538,462 | 0.0% | 0.82% | +48.9% |
| Q3 2019 | $7,677 | – | 1,538,462 | – | 0.55% | – |
Download | ||||||